If you’ve ever dealt with a meniscus injury or know someone who has, you understand the frustration of slow healing and the risk of long-term knee issues like osteoarthritis. The meniscus, that crescent-shaped cushion in your knee, plays a critical role in joint stability and load distribution—yet it has limited self-repair capabilities, especially after injury. Surgery is often the go-to option, but success rates are inconsistent, and recovery can be lengthy. But what if there was a non-invasive way to boost the body’s natural repair mechanisms? A groundbreaking study published in Scientific Reports sheds light on how photobiomodulation (PBM) could revolutionize meniscus treatment by targeting meniscus-derived stem cells (MeSCs). Let’s dive into the science, findings, and future potential of this exciting research.

The Meniscus Injury Crisis: Why Current Treatments Fall Short

First, let’s recap why meniscus injuries are so challenging. The meniscus is a cartilaginous structure that absorbs shock and stabilizes the knee joint. Unlike skin or bone, it has poor blood supply—especially in the inner “white-white” zone—making self-healing difficult. When injured, untreated or poorly repaired menisci often lead to cartilage degeneration, chronic pain, and eventually osteoarthritis (OA). For many patients, total knee replacement becomes necessary, a major surgery with significant recovery time and potential complications.

Stem cell therapy has emerged as a hopeful alternative, with MeSCs (stem cells isolated from the meniscus itself) showing promise. MeSCs are tissue-specific, meaning they’re uniquely adapted to the meniscal microenvironment—making them ideal candidates for regenerative therapy. However, two key hurdles remain: limited availability of MeSCs from injured tissue and reduced cell viability due to the harsh pathological conditions of damaged menisci. This is where PBM steps in.

What Is Photobiomodulation (PBM)?

PBM, also known as low-level light therapy, uses non-thermal lasers or light-emitting diodes (LEDs) to stimulate biological processes. It’s a non-invasive, drug-free modality already used clinically to promote wound healing, reduce inflammation, and enhance tissue repair. In stem cell research, PBM has been shown to boost proliferation, migration, and differentiation—critical for improving the efficacy of cell-based therapies. But until now, its effects on MeSCs and the underlying mechanisms remained largely unexplored.

The Study: Uncovering PBM’s Effect on MeSCs

A team of researchers from institutions across China set out to investigate how PBM—at different wavelengths and energy densities—affects MeSC function. Their goal? To identify optimal PBM parameters and understand the molecular pathways driving its effects. Here’s what they did:

Study Design

The researchers isolated MeSCs from human meniscal tissue (obtained from patients undergoing total knee arthroplasty) and characterized them to confirm their stem cell properties (e.g., surface markers like CD29, CD44, and CD90, and multi-lineage differentiation potential). They then exposed the MeSCs to LED light at four wavelengths (400–405 nm, 500–505 nm, 700–710 nm, 1064 nm) and four energy densities (3, 15, 30, 60 J/cm²). The control group received no irradiation.

To measure PBM’s impact, the team analyzed key outcomes:

• Intracellular calcium (Ca²⁺) levels
• Cytochrome C oxidase (CCO) activity (a mitochondrial enzyme linked to energy production)
• Nitric oxide (NO) concentrations
• Reactive oxygen species (ROS) production
• Cell viability, mitochondrial membrane potential (ΔΨm), and proliferation
• Expression of cell cycle, apoptosis, and senescence-related proteins
• Cellular senescence (via β-galactosidase activity)

They also tested the role of the transient receptor potential vanilloid 1 (TRPV1) channel—a calcium-permeable ion channel—using a specific inhibitor (capsazepine, CPZ) to validate its involvement in PBM’s effects.

Key Findings: Optimal PBM Parameters for MeSC Activation

The results were striking, revealing a clear “biphasic dose response” (beneficial effects at low-to-moderate doses, inhibitory effects at high doses) and a specific mechanism of action:

1. Optimal Wavelengths and Energy Densities: Irradiation at 700–710 nm (near-infrared) and 1064 nm (near-infrared) with energy densities of 3, 15, and 30 J/cm² significantly improved MeSC function. The most dramatic effects were seen at 15 J/cm², where:

• Cell viability and mitochondrial membrane potential (ΔΨm) increased (indicating healthier mitochondria).
• Cell proliferation boosted (higher number of cell doublings, shorter doubling time).
• Expression of pro-survival and cell cycle proteins (Bcl-2, Cyclin D1, CXCR-4) upregulated.
• Expression of apoptosis and senescence-related proteins (Bax, Caspase-3, p16, p53) downregulated.
• Cellular senescence reduced (lower β-galactosidase activity).

2. Inhibitory Effects of Other Parameters: In contrast, wavelengths of 400–405 nm (violet) and 500–505 nm (green)—at all energy densities—and 60 J/cm² (high energy) at all wavelengths had the opposite effect: reduced cell viability, impaired mitochondrial function, decreased proliferation, and increased senescence.
3. Mechanism: TRPV1-Ca²⁺-ROS Signaling Pathway: The study uncovered that PBM’s effects are mediated by the TRPV1 channel. Here’s how it works:

• PBM activates TRPV1, leading to increased intracellular Ca²⁺ influx.
• Elevated Ca²⁺ stimulates moderate ROS production (a key signaling molecule for cell proliferation and survival).
• This cascade enhances mitochondrial function and proliferation while suppressing apoptosis and senescence.
• Critically, inhibiting TRPV1 with CPZ blocked these effects—confirming TRPV1 as the key mediator.

4. No Role for CCO or NO: Surprisingly, the researchers found no significant changes in CCO activity or NO concentrations across any PBM parameters. This challenges earlier hypotheses about PBM’s mechanism in other cell types and highlights that MeSCs respond uniquely to PBM via TRPV1-Ca²⁺-ROS signaling.

Why This Matters for Meniscus Repair

This study is a game-changer for regenerative medicine in knee health for several reasons:

• Targeted, Non-Invasive Pretreatment: PBM can be used to pretreat MeSCs before injection in cell therapy, boosting their viability and proliferation—addressing the key limitations of current MeSC-based treatments.
• Optimal Parameters Identified: The finding that 700–710 nm and 1064 nm at 15 J/cm² are optimal provides a clear roadmap for clinical translation.
• Reduced Senescence: By slowing MeSC aging, PBM ensures that injected cells remain functional longer, enhancing their repair potential.
• Safety: PBM is non-invasive, drug-free, and has minimal side effects—making it a safe adjunct to existing therapies.

Future Directions: From Preclinical to Clinical Application

While this study is preclinical (conducted in vitro), it lays the groundwork for future clinical trials. Here’s what’s next:

• In Vivo Studies: Testing PBM’s effects on MeSCs in animal models of meniscus injury to validate its repair potential in a living system.
• Combination Therapies: Exploring PBM alongside MeSC injection or other regenerative strategies (e.g., scaffolds) to maximize healing.
• Clinical Trials: Evaluating PBM as a standalone treatment for mild-to-moderate meniscus injuries or as a pretreatment for MeSC therapy in humans.
• Personalized Medicine: Tailoring PBM parameters to individual patients based on injury type, age, and other factors.

The study also notes some limitations—for example, MeSCs were isolated from older patients with osteoarthritis, and experiments were conducted in 2D culture. Future research will need to test younger donor MeSCs and 3D culture systems (which better mimic the in vivo environment) to confirm these findings.

Final Thoughts: A Brighter Future for Knee Health

Meniscus injuries don’t have to lead to chronic pain or joint replacement. This study shows that photobiomodulation, by targeting MeSCs via the TRPV1-Ca²⁺-ROS pathway, has the potential to transform how we treat meniscal damage—offering a safe, effective, and non-invasive option to boost natural healing. As research progresses, PBM could become a standard part of meniscus repair protocols, helping patients recover faster and avoid long-term knee complications.

If you’re interested in the latest advancements in regenerative medicine for joint health, stay tuned—this is just the beginning of PBM’s role in transforming orthopedic care.

Reference: Tong, J., Wu, X., Wang, Z., et al. (2025). Photobiomodulation stimulates mitochondrial function and cell proliferation in meniscus-derived stem cells (MeSCs) via activation of TRPV1 channel. Scientific Reports, 15, 43131. https://doi.org/10.1038/s41598-025-27040-7